NSERC is pleased to announce the launch of several improvements to its Alliance grants program.…
karnottDecember 13, 2023
Identification and morphological analysis of mitochondria–ER contacts (MERCs) by fluorescent microscopy is limited by subpixel…
karnottDecember 12, 2023
The Genome Sciences Centre, a leading institution in genomic research and innovation, is proud to…
karnottDecember 11, 2023
Hospital-acquired infections (HAIs) remain one of the major challenges faced by the global healthcare system.…
karnottDecember 11, 2023
Researchers and community members came together to celebrate the latest issue of Pathways Magazine —…
karnottDecember 8, 2023
Like many of his colleagues in cancer research, Dr. Rafael Meza has a personal connection…
karnottDecember 8, 2023
Science Exposed is a contest organized by the Natural Sciences and Engineering Research Council of…
karnottDecember 7, 2023
With British Columbia’s tech sector powering the province’s economic recovery from the COVID-19 pandemic, the BC…
pthomsonJune 24, 2021
Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform…
pthomsonJune 24, 2021
Recipients of the inaugural MSFHR COVID-19 Research Response Fund were announced one year ago and since…
pthomsonJune 18, 2021
Contaminants in generic medications used to treat conditions like diabetes, heart disease, stomachaches and heartburn…
pthomsonJune 17, 2021
Every week, more Canadians are rolling up their sleeves to get the shot that will…
pthomsonJune 15, 2021
The BC Diabetes Research Network is delighted to release our fifth podcast from Season 2…
pthomsonJune 15, 2021
Bold Therapeutics, a clinical-stage biopharmaceutical company, is announcing that the U.S. Food & Drug Administration…
pthomsonJune 14, 2021
The words “cancer” and “hypoxia” frequently come up in the same conversation (in some cases,…
pthomsonJune 11, 2021
